B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment
作者
Nancy Agmon‐Levin,А. В. Гордиенко,Josefina Cortés-Hernández,Pongthorn Narongroeknawin,Katarzyna Romanowska‐Próchnicka,Nan Shen,Hana Ciferská,Piotr Leszczyński,Joung-Liang Lan,Eduardo Mysler,Tünde Tarr,Elena A. Vishnеva,Stephanie Finzel,Alberta Hoi,Masato Okada,Shin‐Seok Lee,Lie Dai,Hiroshi Kaneko,Bernadette Rojkovich,Lingyun Sun